Growth Metrics

Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2020 - 2025)

Gilead Sciences (GILD) has disclosed Non-Current Deferred Tax Liability for 10 consecutive years, with $597.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 24.81% year-over-year to $597.0 million, compared with a TTM value of $597.0 million through Sep 2025, down 24.81%, and an annual FY2024 reading of $724.0 million, down 54.41% over the prior year.
  • Non-Current Deferred Tax Liability was $597.0 million for Q3 2025 at Gilead Sciences, down from $652.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $4.6 billion in Q3 2021 and bottomed at $597.0 million in Q3 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.3 billion, with a median of $2.1 billion recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability increased 11.29% in 2021, then plummeted 61.14% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $4.4 billion in 2021, then tumbled by 38.64% to $2.7 billion in 2022, then tumbled by 40.59% to $1.6 billion in 2023, then plummeted by 54.41% to $724.0 million in 2024, then decreased by 17.54% to $597.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for GILD at $597.0 million in Q3 2025, $652.0 million in Q2 2025, and $709.0 million in Q1 2025.